Neoadjuvant Abemaciclib plus Letrozole vs. Chemotherapy in patients with HR+/HER2- Highly Proliferative Breast Cancer. Martin M, Guerrero-Zotano AL, Perez-Lopez ME, Ruiz-Borrego M, et al. Clin Cancer Res 2025 Dec 12. doi: 10.1158/1078-0432.CCR-25-2435.

Read + Share

Amedeo Smart

Independent Medical Education

Martin M, Guerrero-Zotano AL, Perez-Lopez ME, Ruiz-Borrego M, et al. Neoadjuvant Abemaciclib plus Letrozole vs. Chemotherapy in patients with HR+/HER2- Highly Proliferative Breast Cancer. Clin Cancer Res 2025 Dec 12. doi: 10.1158/1078-0432.CCR-25-2435.
PMID: 41385615